Reasons for the difference and revisions
First-half forecast for fiscal year 2022
Net sales, operating income, and all other profit indicators are expected to surpass the previously issued forecast due to improvements in overseas market conditions for methylene diphenyl diisocyanate (MDI) and improvement in the difference between inventory receipts and payments.
Full-year forecast for fiscal year 2022
As a result of the upturn in the first half of the fiscal year, net sales, operating income, and all other profit indicators are expected to surpass the previously issued forecast.
Note
Forecasts are based on information available to the company as of the date of the news release. Actual results may differ due to unforeseeable factors.
Who We Are
What We Do
DISCLAIMER
This document may contain forward-looking statements, including, without limitation, statements concerning product development, objectives, goals, and commercial introductions, which involve certain risks and uncertainties. Forward-looking statements are identified through the use of the word anticipates and other words of similar meaning. Actual results may differ significantly from the results expressed in forward-looking statements.
Contact:
Tel: +81 3 5427 5118
Fax: +81 3 5427 5198
Email: lisa.lee@tosoh.com
(C) 2021 Electronic News Publishing, source